Health Care: Drugs

Neostem Inc (NBS: NASDAQ)

$6.17 -0.05 | -0.8%
07/31/14 - 04:00 PM ET
Company Income Statement
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Sales 14.67M 14.33M 73.72M 69.82M
Cost of Sales 11.34M 8.79M 44.56M 44.25M
Gross Operating Profit 3.33M 5.54M 29.16M 25.57M
Selling, General, and Administrative Expenses 21.61M 22.32M 41.85M 31.35M
Research & Development 16.92M 10.45M 11.00M 7.68M
Operating Income before D & A (EBITDA) -35.20M -27.23M -23.69M -13.46M
Depreciation & Amortization 1.61M 3.16M 11.42M 5.42M
Interest Income 0.00 0.00 0.00 0.00
Other Income - Net -1.61M -4.31M 2.34M 513.11K
Special Income / Charges 0.00 0.00 -19.43M 0.00
Total Income Before Interest Expenses (EBIT) -38.42M -34.70M -52.20M -18.37M
Interest Expense 281.42K 1.58M 3.99M 480.90K
Pre-Tax Income -38.71M -36.28M -56.19M -18.85M
Income Taxes 780.10K -175.53K 392.77K 550.91K
Minority Interest -504.09K -12.60M -9.45M 3.91M
Net Income From Continuing Operations -39.49M -36.10M -56.58M -19.40M
Net Income From Discontinued Operations 0.00 -30.27M 0.00 0.00
Net Income From Total Operations -39.49M -66.37M -56.58M -19.40M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -38.98M -53.77M -47.13M -23.31M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-39.49M -36.10M -37.15M -19.40M
Preferred Dividends
Net Income Available To Common -39.49M -36.63M -57.22M -19.63M
Basic EPS from Continuing Ops. -1.90 -2.60 -5.39 -4.56
Basic EPS from Discontinued Ops. 0.00 -1.30 0.00 0.00
Basic EPS from Total Operations -1.90 -3.90 -5.39 -4.56
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 -0.10 -0.01 -0.04
Basic EPS, Total -1.90 -4.00 -5.40 -4.60
Basic Normalized Net Income/Share -1.90 -2.60 -3.54 -4.56
EPS fr Continuing Ops. -1.90 -2.60 -5.39 -4.56
EPS fr Discontinued Ops 0.00 -1.30 0.00 0.00
EPS fr Total Ops. -1.90 -3.90 -5.39 -4.56
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 -0.10 -0.01 -0.04
EPS, Total -1.90 -4.00 -5.40 -4.60
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.90 -2.60 -3.54 -4.56
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with NBS

Latest NBS Headlines from TheStreet

More Financial News for NBS

Press Releases for NBS

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter